Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02433548

Enrollment

Registered

2015-05-05

Start date

2014-10-31

Completion date

2016-08-31

Last updated

2016-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fracture

Keywords

Analgesia, Emergency medicine, Anesthesia, Regional

Brief summary

Femoral neck fracture is very common in the elderly and can produce severe to moderate pain. As this pathology is not life-threatening, waiting time in the emergency department may be prolonged due to the high number of unforeseen cases with patients remaining in pain. Fascia iliaca block consists of injecting local anaesthetics below the fascia iliaca, resulting in the anaesthesia of the femoral, the lateral cutaneous and the obturator nerves, with effective analgesia.

Detailed description

The objective of this trial is to compare the fascia iliaca block with a sham injection on patients arriving in the emergency department with a femoral neck fracture. The fascia iliaca block will be performed with an anatomical landmark technique and a volume of 30 mLs of bupivacaine 0.5% with epinephrine 5 mcg/mL will be injected.

Interventions

PROCEDUREFascia iliaca block

injection of 30 mLs below the fascia iliaca

PROCEDURESham injection

subcutaneous of 5 cc of normal saline

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

\- patients with femoral neck fracture in the emergency department

Exclusion criteria

* presence of demencia * body weight less than 40kg * presence of a cancer or patients receiving chemotherapy * allergy to local anaesthetics

Design outcomes

Primary

Measure	Time frame
Pain scores at rest	45 minutes after the injection

Secondary

Measure	Time frame
Pain scores at rest	60 min, 4h, 8h, 12h, 24h after the injection
Pain scores on movement	60 min, 4h, 8h, 12h, 24h after the injection
Morphine consumption	60 min, 4h, 8h, 12h, 24h after the injection
Length of stay	up to 3 weeks

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026